NCT01148628 - Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

December 31, 2011

Conditions

Advanced Solid Tumors

Interventions

DRUG

RAD 001 in combination with Caelyx

RAD001 (tablets; 2.5mg) is administered daily at 5, 7.5, 10 mg. CAELYXTM (vials; 50 mg/25mL)is administered i.v.every 4 weeks at 40mg/m2. One treatment cycle is 4 weeks.

Trial Locations (3)

6500

Istituto Oncologico della Svizzera Italiana, Bellinzona

20133

Fondazione IRCSS Istituto Nazionale dei Tumori, Milan

20141

Istituto Europeo di Oncologia, Milan